[{"indications": "Indications\u00a0symptomatic relief of gastro-intestinal\r\ndisorders characterised by smooth muscle spasm; mydriasis and cycloplegia\r\n(section 11.5); premedication (section 15.1.3); see also notes above", "name": "ATROPINE SULPHATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.2 Antispasmodics and other drugs altering gut motility", "Antimuscarinics", "ATROPINE SULPHATE"], "cautions": "Cautions\u00a0\n(From Antimuscarinics: British National Formulary)\nCautions\u00a0Antimuscarinics should be used with caution in Down\u2019s syndrome, in children and in the elderly; they should also be used with caution in gastro-oesophageal reflux disease, diarrhoea, ulcerative colitis, autonomic neuropathy, acute myocardial infarction, hypertension, conditions characterised by tachycardia (including hyperthyroidism, cardiac insufficiency, cardiac surgery), pyrexia, and in individuals susceptible to angle-closure glaucoma. Interactions: Appendix 1 (antimuscarinics).", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/60253.htm", "doses": ["0.6\u20131.2\u00a0mg at night"], "pregnancy": "Pregnancy\u00a0manufacturer advises caution"}, {"indications": "Indications\u00a0premedication; intra-operative\r\nbradycardia; with anticholinesterases for reversal of non-depolarising\r\nneuromuscular block; antidote to organophosphorous poisoning (see Emergency Treatment of Poisoning); symptomatic relief of gastro-intestinal\r\ndisorders characterised by smooth muscle spasm (section 1.2); bradycardia (section 2.3.1); cardiopulmonary\r\nresuscitation (section 2.7.3); cycloplegia,\r\nanterior uveitis (section 11.5)", "name": "ATROPINE SULPHATE - ANTIMUSCARINIC DRUGS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.1 General anaesthesia", "15.1.3 Antimuscarinic drugs", "ATROPINE SULPHATE"], "cautions": "Cautions\u00a0see notes in section 1.2Duration of action\u00a0Since atropine\r\nhas a shorter duration of action than neostigmine, late unopposed bradycardia may result; close monitoring of the\r\npatient is necessary", "side-effects": "Side-effects\u00a0see notes in section 1.2", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6585.htm", "doses": ["Premedication, by intravenous injection, 300\u2013600\u00a0micrograms immediately before induction of anaesthesia; child under 12 years see BNF for Children", "By subcutaneous or intramuscular injection, 300\u2013600\u00a0micrograms 30\u201360 minutes before induction of anaesthesia; child under 12 years see BNF for Children", "Intra-operative bradycardia, by intravenous\r\ninjection, 300\u2013600\u00a0micrograms (larger doses in emergencies); child under 12 years see BNF for Children", "Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block, by intravenous\r\ninjection, 0.6\u20131.2\u00a0mg; child under 12 years see BNF for Children", "Control of muscarinic side-effects of edrophonium in reversal of competitive neuromuscular block [unlicensed indication], by intravenous injection, 600\u00a0micrograms; child under 18 years see BNF for Children", "Arrhythmias after myocardial infarction, see section 2.3.1"], "pregnancy": "Pregnancy\u00a0not known to be harmful; use with caution"}, {"indications": "Indications\u00a0symptomatic relief of gastro-intestinal\r\ndisorders characterised by smooth muscle spasm; mydriasis and cycloplegia\r\n(section 11.5); premedication (section 15.1.3); see also notes above", "name": "ATROPINE SULPHATE - ANTIMUSCARINICS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.2 Antispasmodics and other drugs altering gut motility", "Antimuscarinics", "ATROPINE SULPHATE"], "cautions": "Cautions\u00a0\n(From Antimuscarinics: British National Formulary)\nCautions\u00a0Antimuscarinics should be used with caution in Down\u2019s syndrome, in children and in the elderly; they should also be used with caution in gastro-oesophageal reflux disease, diarrhoea, ulcerative colitis, autonomic neuropathy, acute myocardial infarction, hypertension, conditions characterised by tachycardia (including hyperthyroidism, cardiac insufficiency, cardiac surgery), pyrexia, and in individuals susceptible to angle-closure glaucoma. Interactions: Appendix 1 (antimuscarinics).", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/60253.htm", "doses": ["0.6\u20131.2\u00a0mg at night"], "pregnancy": "Pregnancy\u00a0manufacturer advises caution"}]